Goldman Sachs
CLB icon

Goldman Sachs’s Core Laboratories CLB Stock Holding History

Goldman Sachs’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-100
Closed -$15K – 6566
2013
Q2 		$15K Buy
+100
New +$14.2K ﹤0.01% 6214

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs's CLB Position: Q2 2026 in Review

Goldman Sachs reduced its Core Laboratories (CLB) stake by 11% in Q2 2026, selling an estimated $1.39M and leaving 751,643 shares worth $8.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3362.

Goldman Sachs first reported a position in CLB in Q2 2013 and has held it in 53 quarters since. The position peaked at $103M in Q3 2014. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Goldman Sachs held 751,643 shares of Core Laboratories worth $8.76M as of Q2 2026.
  • Goldman Sachs sold 97,258 Core Laboratories shares in Q2 2026, an estimated $1.39M.
  • Core Laboratories made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3362 holding.
  • Goldman Sachs first reported a position in Core Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Core Laboratories position peaked at $103M in Q3 2014.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.